Intervention Protocol

Somatostatin analogues for treatment of enterocutaneous fistula

  1. Philip Stevens1,*,
  2. Sorrel Burden2,
  3. Raymond Delicata3,
  4. Gordon Carlson4,
  5. Simon Lal5

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 30 APR 2013

DOI: 10.1002/14651858.CD010489

How to Cite

Stevens P, Burden S, Delicata R, Carlson G, Lal S. Somatostatin analogues for treatment of enterocutaneous fistula (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD010489. DOI: 10.1002/14651858.CD010489.

Author Information

  1. 1

    Salford Royal NHS Foundation Trust, Surgery, Salford, UK

  2. 2

    University of Manchester, School of Nursing, Midwifery and Social Work, Manchester, UK

  3. 3

    Gwent Healthcare NHS Healthboard ? Nevill Hall Hospital, General Surgery, Abergavenny, UK

  4. 4

    Salford Royal NHS Foundation Trust, General Surgery, Salford, UK

  5. 5

    Salford Royal Foundation Trust, Intestinal Failure Unit, Salford, UK

*Philip Stevens, Surgery, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK. Stevens_P1@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 30 APR 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objectives of this review are to assess the efficacy and safety of somatostatin and somatostatin analogues for the treatment of ECF and EAF.